Tratamiento combinado de fotocoagulación panretiniana y fármacos antiangiogénicos en la retinopatía diabética proliferativa
Alerta, Revista científica del Instituto Nacional de Salud · 25.10.2026 · 9 (4) · 333-339
DOI: 10.5377/alerta.v9i4.23763 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alerta, Revista científica del Instituto Nacional de Salud, online erschienen am 25.10.2026. Verfasst von Mauricio Alexander Rodríguez Aranda und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Proliferative diabetic retinopathy is a major cause of vision loss due to neovascularization, vitreous hemorrhage, and retinal traction. A review article was conducted to explore the evidence on the efficacy of the combination of panretinal photocoagulation and antiangiogenic drugs in proliferative diabetic retinopathy and to identify its benefits and limitations. A literature search was conducted in Medline (via PubMed) and LILACS from April through August 2025. The following descriptors and search terms were used: "Diabetic retinopathy," "photocoagulation," "angiogenesis inhibitors," and "retinal neovascularization." English-language publications (clinical trials, observational studies, and reviews) were included. The search identified 50 articles; after removing duplicates, 44 studies were evaluated, and six were excluded because they were not relevant to the review’s objective. Of the 38 articles reviewed, four were excluded based on inclusion and exclusion criteria (two guidelines and two aged more than five years). A total of 34 articles were included. Overall, combination therapy accelerates neovascular regression, reduces early vitreous hemorrhage, and attenuates post-laser macular thickening; furthermore, several studies show advantages in short- and medium-term visual acuity compared with panretinal photocoagulation alone, with an acceptable safety profile. Clinical benefit appears to depend on adherence, treatment sequencing, and access to follow-up; uncertainties remain regarding optimal regimens and sustained long-term functional outcomes.
Zitieren
APA
Aranda, M. A. R., Escobar, O. E. P., & Turcios, E. A. R. (2026). Tratamiento combinado de fotocoagulación panretiniana y fármacos antiangiogénicos en la retinopatía diabética proliferativa. Alerta, Revista científica del Instituto Nacional de Salud, 9(4), 333-339. https://doi.org/10.5377/alerta.v9i4.23763
Vancouver
Aranda MAR, Escobar OEP, Turcios EAR. Tratamiento combinado de fotocoagulación panretiniana y fármacos antiangiogénicos en la retinopatía diabética proliferativa. Alerta, Revista científica del Instituto Nacional de Salud. 2026;9(4):333-339. doi:10.5377/alerta.v9i4.23763
BibTeX
@article{Aranda2026,
author = {Aranda, Mauricio Alexander Rodríguez and Escobar, Oscar Elías Portillo and Turcios, Eric Antonio Rodríguez},
title = {Tratamiento combinado de fotocoagulación panretiniana y fármacos antiangiogénicos en la retinopatía diabética proliferativa},
journal = {Alerta, Revista científica del Instituto Nacional de Salud},
year = {2026},
volume = {9},
number = {4},
pages = {333--339},
doi = {10.5377/alerta.v9i4.23763}
}
EUVIMED